A prospective observational study of vitamin D3 level in reproductive age group women with uterine leiomyoma

Annesha Dutta; Murari Mohan Koley; Priti Gautam

doi:10.18203/2320-1770.ijrcog20231231

Authors

Annesha Dutta Department of Obstetrics and Gynecology, AIIMS Kalyani, West Bengal, India
Murari Mohan Koley Department of Obstetrics and Gynecology, District Hospital Howrah, West Bengal, India
Priti Gautam Department of Obstetrics and Gynecology, Calcutta National Medical College, West Bengal, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20231231

Keywords:

Risk factor, Uterine fibroid, Uterine leiomyoma, Vitamin D deficiency

Abstract

Background: Uterine leiomyomas are the commonest benign tumours of the uterus with the incidence between 5.4 to 77% in Indian women. Vitamin D deficiency is a proven risk factor in the pathogenesis of uterine fibroid in many studies conducted in different parts of the world but not many studies have been conducted on Indian women.

Methods: A total of 200 women of age group 18 to 45 years attending District Hospital, Howrah, West Bengal, were included in the study. Out of which, 100 had leiomyoma and rest healthy women without leiomyoma serves as controls. Routine ultrasound examination and serum hormone analysis of Vitamin D₃ were done. Serum FSH, LH were done on day 2 of menstruation. Statistical analysis of data was performed using SPSS Version 22 software.

Results: The mean serum concentration of vitamin D₃ was significantly lower in women with uterine fibroids compared to controls (12.66±5.42 versus 25.91±14.18, p<0.003). On further analysis, 68.4% of cases were found to be severely deficient (vitamin D₃ <9 ng/ml) as compared to 27.12% of controls (p<0.0002). Besides that, only 3.67% of cases had sufficient vitamin D level as compared to 22.16% of controls (p<0.0002). The odds ratio (OR) of occurrence of fibroid with serum vitamin D₃ level of <12 ng/dl compared to that level >12 ng/dl was 5.38 (95% CI- 2.12-9.45) (p<0.0001).

Conclusions: Serum vitamin D₃ level inversely correlated with the burden of leiomyoma and possibly its deficiency is a causative factor for the occurrence of uterine fibroid in the reproductive age group women.

Metrics

Metrics Loading ...

References

Myers ER, Barber MD, Gustilo-Ashby T, Couchman G, Matchar DB, McCrory DC. Management of uterine leiomyomata: what do we really know? Obstet Gynecol. 2002;100:8-17.

Laughlin SK, Schroeder JC, Baird DD. New directions in the epi- demiology of uterine fibroids. Semin Reprod Med. 2010;28:204-17.

Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100-7.

Somigliana E, Vercellini P, Daguati R, Pasin R, De Giorgi O, Crosignani PG. Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update. 2007;13:465-76.

Luk J, Torrealday S, NealPerry G, Pal L. Relevance of vitamin D in reproduction. Hum Reprod. 2012;27:3015-27.

Sabry M, Al-Hendy A. Innovative oral treatments of uterine leio- myoma. Obstet Gynecol Int. 2012:943635.

Bläuer M, Rovio PH, Ylikomi T, Heinonen PK. Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro. Fertil Steril. 2009;91:1919-25.

Sharan C, Halder SK, Thota C, Jaleel T, Nair S, Al-Hendy A. Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase. Fertil Steril. 2011;95:247-53.

Halder SK, Goodwin JS, Al-Hendy A. 1,25-dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in hu- man uterine leiomyoma cells. J Clin Endocrinol Metab. 2011;96:E754-62.

Halder SK, Sharan C, Al-Hendy A. 1,25-Dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model. Biol Reprod. 2012;86:116.

Sabry M, Halder SK, Allah AS, Roshdy E, Rajaratnam V, Al-Hendy A. Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: a cross-sectional observational study. Int J Womens Health. 2013;5:93-100.

Khyade RL. A study of menstrual disturbances in cases of fibroid uterus. Int J Reprod Contracept Obstet Gynecol. 2017;6:2494-7.

Paffoni A, Somigliana E, Vigano' P, Benaglia L, Cardellicchio L, Pagliardini L, et al. Vitamin D status in women with uterine leiomyomas. J Clin Endocrinol Metab. 2013;98(8):E1374-8.

Lippman SA, Warner M, Samuels S, Olive D, Vercellini P, Eskenazi B. Uterine fibroids and gynecologic pain symptoms in a population-based study. Fertil Steril. 2003;80(6):1488-94.

Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect. 2003;111:1037-54.

Kjerulff K, Langenberg P, Seidman J, Stolley P, Guzinski G. Uterine leiomyomas: racial differences in severity, symptoms and age at diagnosis. J Reprod Med. 1996;41:483-90.

Bouyer J, Job‐Spira N, Pouly JL, Coste J, Germain E, Fernandez H. Fertility following radical, conservative‐surgical or medical treatment for tubal pregnancy: a population‐based study. BJOG. 2000;107(6):714-21.

Pérez-López FR, Ornat L, Ceausu I, Depypere H, Erel CT, Lambrinoudaki I, et al. EMAS position statement: management of uterine fibroids. Maturitas. 2014;79(1):106-16.

Parker WH. Etiology, symptomatology and diagnosis of uterine myomas. Fertil Steril. 2007;87:725-36.

Olive DL, Lindheim SR, Pritts EA. Non-surgical management of leiomyoma: impact on fertility. Curr Opin Obstet Gynecol. 2004;16:239-43.

Sharan C, Halder SK, Thota C, Jaleel T, Nair S, Al-Hendy A. Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase. Fertil Steril. 2011;95(1):247-53.

Ylikomi T, Laaksi I, Lou YR, Martikainen P, Miettinen S, Pennanen P, et al. Antiproliferative action of vitamin D. Vitamins Hormones. 2002;64:357-406.

Gupta A. Vitamin D deficiency in India: prevalence, causalities and interventions. Nutrients. 2014;6(2):729-75.